Portfolio Update

Intl. Biotechnology Trust PLC
11 December 2007



                                                                11 December 2007







                         PORTFOLIO COMPANY TRANSACTION





The Board of International Biotechnology Trust plc (the 'Company') notes that on
10 December 2007, Eisai agreed to buy portfolio company MGI Pharma for US$3.9m
(US$41) per share, representing a 23% premium on the closing price on Friday, 7
December 2007.



If the purchase price for MGI Pharma had been included in the net asset value of
7 December, this would have added 1.4p (1.0%) to the Company's net asset value
per ordinary share.







Enquiries:



Andy Smith

SV Life Sciences Managers LLP


Investment Manager                                    Tel: [phone]



Louise Richard

Schroder Investment Management Limited                Tel: [phone]




                      This information is provided by RNS
            The company news service from the London Stock Exchange